Literature DB >> 24592289

Integrative immunoinformatics for Mycobacterial diseases in R platform.

Rupanjali Chaudhuri1, Deepika Kulshreshtha1, Muthukurussi Varieth Raghunandanan1, Srinivasan Ramachandran1.   

Abstract

The sequencing of genomes of the pathogenic Mycobacterial species causing pulmonary and extrapulmonary tuberculosis, leprosy and other atypical mycobacterial infections, offer immense opportunities for discovering new therapeutics and identifying new vaccine candidates. Enhanced RV, which uses additional algorithms to Reverse Vaccinology (RV), has increased potential to reduce likelihood of undesirable features including allergenicity and immune cross reactivity to host. The starting point for MycobacRV database construction includes collection of known vaccine candidates and a set of predicted vaccine candidates identified from the whole genome sequences of 22 mycobacterium species and strains pathogenic to human and one non-pathogenic Mycobacterium tuberculosis H37Ra strain. These predicted vaccine candidates are the adhesins and adhesin-like proteins obtained using SPAAN at Pad > 0.6 and screening for putative extracellular or surface localization characteristics using PSORTb v.3.0 at very stringent cutoff. Subsequently, these protein sequences were analyzed through 21 publicly available algorithms to obtain Orthologs, Paralogs, BetaWrap Motifs, Transmembrane Domains, Signal Peptides, Conserved Domains, and similarity to human proteins, T cell epitopes, B cell epitopes, Discotopes and potential Allergens predictions. The Enhanced RV information was analysed in R platform through scripts following well structured decision trees to derive a set of nonredundant 233 most probable vaccine candidates. Additionally, the degree of conservation of potential epitopes across all orthologs has been obtained with reference to the M. tuberculosis H37Rv strain, the most commonly used strain in M. tuberculosis studies. Utilities for the vaccine candidate search and analysis of epitope conservation across the orthologs with reference to M. tuberculosis H37Rv strain are available in the mycobacrvR package in R platform accessible from the "Download" tab of MycobacRV webserver. MycobacRV an immunoinformatics database of known and predicted mycobacterial vaccine candidates has been developed and is freely available at http://mycobacteriarv.igib.res.in.

Entities:  

Keywords:  Enhanced RV; Mycobacteria; Reverse Vaccinology; Vaccine

Year:  2014        PMID: 24592289      PMCID: PMC3933634          DOI: 10.1007/s11693-014-9135-9

Source DB:  PubMed          Journal:  Syst Synth Biol        ISSN: 1872-5325


  62 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages.

Authors:  L Y Armitige; C Jagannath; A R Wanger; S J Norris
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Broad institute: bringing genomics to real-world medicine.

Authors:  Alice A McCarthy
Journal:  Chem Biol       Date:  2005-07

4.  Prediction of residues in discontinuous B-cell epitopes using protein 3D structures.

Authors:  Pernille Haste Andersen; Morten Nielsen; Ole Lund
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

5.  A systematic bioinformatics approach for selection of epitope-based vaccine targets.

Authors:  Asif M Khan; Olivo Miotto; A T Heiny; Jerome Salmon; K N Srinivasan; Eduardo J M Nascimento; Ernesto T A Marques; Vladimir Brusic; Tin Wee Tan; J Thomas August
Journal:  Cell Immunol       Date:  2007-04-16       Impact factor: 4.868

6.  Identification of a universal Group B streptococcus vaccine by multiple genome screen.

Authors:  Domenico Maione; Immaculada Margarit; Cira D Rinaudo; Vega Masignani; Marirosa Mora; Maria Scarselli; Hervé Tettelin; Cecilia Brettoni; Emilia T Iacobini; Roberto Rosini; Nunzio D'Agostino; Lisa Miorin; Scilla Buccato; Massimo Mariani; Giuliano Galli; Renzo Nogarotto; Vincenzo Nardi-Dei; Vincenzo Nardi Dei; Filipo Vegni; Claire Fraser; Giuseppe Mancuso; Giuseppe Teti; Lawrence C Madoff; Lawrence C Paoletti; Rino Rappuoli; Dennis L Kasper; John L Telford; Guido Grandi
Journal:  Science       Date:  2005-07-01       Impact factor: 47.728

7.  Signal peptide cleavage of a type I membrane protein, HCMV US11, is dependent on its membrane anchor.

Authors:  A Rehm; P Stern; H L Ploegh; D Tortorella
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 8.  Reverse vaccinology: developing vaccines in the era of genomics.

Authors:  Alessandro Sette; Rino Rappuoli
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

9.  BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control.

Authors:  Corinne S C Merle; Sergio S Cunha; Laura C Rodrigues
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  6 in total

Review 1.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 2.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

3.  Computational B-cell epitope identification and production of neutralizing murine antibodies against Atroxlysin-I.

Authors:  Edgar Ernesto Gonzalez Kozlova; Loïc Cerf; Francisco Santos Schneider; Benjamin Thomas Viart; Christophe NGuyen; Bethina Trevisol Steiner; Sabrina de Almeida Lima; Franck Molina; Clara Guerra Duarte; Liza Felicori; Carlos Chávez-Olórtegui; Ricardo Andrez Machado-de-Ávila
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

4.  Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse Vaccinology.

Authors:  Gloria P Monterrubio-López; Jorge A González-Y-Merchand; Rosa María Ribas-Aparicio
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

Review 5.  Identification of Mycobacterium tuberculosis adherence-mediating components: a review of key methods to confirm adhesin function.

Authors:  Saiyur Ramsugit; Manormoney Pillay
Journal:  Iran J Basic Med Sci       Date:  2016-06       Impact factor: 2.699

6.  A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis.

Authors:  Sandeep Kumar Dhanda; Pooja Vir; Deepak Singla; Sudheer Gupta; Shailesh Kumar; Gajendra P S Raghava
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.